Selective inhibition of the collagenolytic activity of human cathepsin K by altering its S2 subsite specificity

被引:92
作者
Lecaille, F
Choe, Y
Brandt, W
Li, ZQ
Craik, CS
Brömme, D
机构
[1] Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA
[2] Univ Calif San Francisco, Dept Pharmaceut Chem, Program Chem & Chem Biol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA
[4] Univ Halle Wittenberg, Inst Plant Biochem, Halle An Der Saale, Germany
关键词
D O I
10.1021/bi025638x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The primary specificity of papain-like cysteine proteases (family C1, clan CA) is determined by S2-P2 interactions. Despite the high amino acid sequence identities and structural similarities between cathepsins K and L, only cathepsin K is capable of cleaving interstitial collagens in their triple helical domains. To investigate this specificity, we have engineered the S2 pocket of human cathepsin K into a cathepsin L-like subsite. Using combinatorial fluorogenic substrate libraries, the P1-P4 substrate specificity of the cathepsin K variant, Tyr67Leu/Leu205Ala, was determined and compared with those of cathepsins K and L. The introduction of the double mutation into the S2 subsite of cathepsin K rendered the unique S2 binding preference of the protease for proline and leucine residues into a cathepsin L-like preference for bulky aromatic residues. Homology modeling and docking calculations supported the experimental findings. The cathepsin L-like S2 specificity of the mutant protein and the integrity of its catalytic site were confirmed by kinetic analysis of synthetic di- and tripeptide substrates as well as pH stability and pH activity profile studies. The loss of the ability to accept proline in the S2 binding pocket by the mutant protease completely abolished the collagenolytic activity of cathepsin K whereas its overall gelatinolytic activity remained unaffected. These results indicate that Tyr67 and Leu205 play a key role in the binding of proline residues in the S2 pocket of cathepsin K and are required for its unique collagenase activity.
引用
收藏
页码:8447 / 8454
页数:8
相关论文
共 36 条
[11]   BINDING OF CHLOROMETHYL KETONE SUBSTRATE ANALOGS TO CRYSTALLINE PAPAIN [J].
DRENTH, J ;
KALK, KH ;
SWEN, HM .
BIOCHEMISTRY, 1976, 15 (17) :3731-3738
[12]   PHAGOCYTOSIS OF BONE-COLLAGEN BY OSTEOCLASTS IN 2 CASES OF PYCNODYSOSTOSIS [J].
EVERTS, V ;
ARONSON, DC ;
BEERTSEN, W .
CALCIFIED TISSUE INTERNATIONAL, 1985, 37 (01) :25-31
[13]  
GAMERO P, 1998, J BIOL CHEM, V273, P32347
[14]   ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY - A RAPID ACCESS TO ATOMIC CHARGES [J].
GASTEIGER, J ;
MARSILI, M .
TETRAHEDRON, 1980, 36 (22) :3219-3228
[15]   Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency [J].
Gelb, BD ;
Shi, GP ;
Chapman, HA ;
Desnick, RJ .
SCIENCE, 1996, 273 (5279) :1236-1238
[16]   Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries [J].
Harris, JL ;
Backes, BJ ;
Leonetti, F ;
Mahrus, S ;
Ellman, JA ;
Craik, CS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (14) :7754-7759
[17]   Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis [J].
Hou, WS ;
Brömme, D ;
Zhao, YM ;
Mehler, E ;
Dushey, C ;
Weinstein, H ;
Miranda, CS ;
Fraga, C ;
Greig, F ;
Carey, J ;
Rimoin, DL ;
Desnick, RJ ;
Gelb, BD .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (05) :731-738
[18]   Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix [J].
Kafienah, W ;
Brömme, D ;
Buttle, DJ ;
Croucher, LJ ;
Hollander, AP .
BIOCHEMICAL JOURNAL, 1998, 331 :727-732
[19]   ACTION OF RAT-LIVER CATHEPSIN-L ON COLLAGEN AND OTHER SUBSTRATES [J].
KIRSCHKE, H ;
KEMBHAVI, AA ;
BOHLEY, P ;
BARRETT, AJ .
BIOCHEMICAL JOURNAL, 1982, 201 (02) :367-372
[20]   Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates [J].
Li, ZQ ;
Hou, WS ;
Brömme, D .
BIOCHEMISTRY, 2000, 39 (03) :529-536